The EPOch of Treatment Innovation: Triumphs and Pitfalls of Government, Big Pharma, and Nephrology in the Development of rEPO

Host Andrew Cohen, MD, discusses the advent of recombinant erythropoietin (rEPO) and its impact on kidney care with Paul Kimmel, MD, FASN; Daniel Coyne, MD; and Ajay Singh, MD.